The Ability of Choline Derivatives Synthesized by Multi-component Reactions in the Inhibition of AChE Enzyme

Authors

  • Zinah A. Al-shareeda Peoples Friendship University of Russia (RUDN University), Moscow, Russia
  • R. A. Abramovich Peoples Friendship University of Russia (RUDN University), Moscow, Russia
  • O. G. Potanina Peoples Friendship University of Russia (RUDN University), Moscow, Russia
  • Hasan M. Alhejoj Peoples Friendship University of Russia (RUDN University), Moscow, Russia
  • A. V. Khromov Peoples Friendship University of Russia (RUDN University), Moscow, Russia

Abstract

Multi-component reactions (MCRs) are strong synthetic tools in which more than two starting materials are coupled together with a purpose to form the multi-functionalized compounds in a one-pot process. In this procedure, they used an additional step without changing the solvent, the so-called sequential-addition procedure, to limit the number of synthetic steps while increasing the complexity and the molecular diversity, which are highly step-economical reactions. The Ugi reaction, one of the most common multi-component reactions, has recently fascinated chemists with the high diversity brought by its four- or three-component-based isonitrile. The Ugi reaction has been introduced in organic synthesis as a novel, efficient and useful tool for the preparation of libraries of multifunctional peptides, natural products, and heterocyclic compounds with stereochemistry control.

Keywords:

AChE, Alzheimer disease, Bis amides, Carbamates, Inhibition, Multi-component reactions (MCRs), Nuclear magnetic resonance (NMR), Screening

References

1. Kendall MJ, Chellingsworth MC, Main An Therapeutic Progress-Review XVIII Alzheimer's Disease. Journal of Clinical Pharmacy and Therapeutics. 1985 Aug;10(4):327-336.

2. Leon J. Thal, MD Wilma Rosen, Howard Crystal, First published: December 1981https://doi.org/10.1002/ana.410100617155

3. S. Milpitas Blvd., Milpitas, CA 95035 USA | T: (408)493-1800 F: (408)493-1801 | www.biovision.com | tech@biovision.com

4. Passerini, M. Gazz. Chim. Ital. 1921;51:126.

5. Ugi, I., et. al. Angew. Chem. 1959, 71, 386

6. A.d. F. S. Barreto, V. A. d. Santos and C. K. Z. Andrade, Beilstein J. Org. Chem., 2016, 12, 2865-2872

7. Ayoup MS, Fouad MA, Abdel-Hamid H, Abu-Serie MM, Noby A, Teleb M. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis. European journal of medicinal chemistry. 2020 Jan 15;186:111875.

8. Taslimi P, Osmanova S, Caglayan C, Turkan F, Sardarova S, Farzaliyev V, Sujayev A, Sadeghian N, Gulçin İ. Novel amides of 1, 1-bis-(carboxymethylthio)-1-arylethanes: Synthesis, characterization, acetylcholinesterase, butyrylcholinesterase, and carbonic anhydrase inhibitory properties. Journal of biochemical and molecular toxicology. 2018 Sep;32(9):e22191.

9. Boyle NA, Talesa V, Giovannini E, Rosi G, Norton SJ. Synthesis and study of thiocarbonate derivatives of choline as potential inhibitors of acetylcholinesterase. Journal of medicinal chemistry. 1997 Sep 12;40(19):3009-30013.

10. Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vasic VM. Acetylcholinesterase inhibitors: pharmacology and toxicology. Current neuropharmacology. 2013 May 1;11(3):315-335.

11. Darvesh S, Darvesh KV, McDonald RS, Mataija D, Walsh R, Mothana S, Lockridge O, Martin E. Carbamates with Differential Mechanism of Inhibition Toward Acetylcholinesterase and Butyrylcholinesterase. J. Med. Chem. 2008;51:4200-4212.

Published

2021-09-22
Statistics
Abstract Display: 0
PDF Downloads: 0